Sexual lubricants in South Africa may potentially disrupt mucosal surfaces and increase HIV transmission risk among men who have sex with men by Rebe, Kevin B et al.
RESEARCH
49       January 2014, Vol. 104, No. 1
Men who have sex with men (MSM) are at high 
risk for HIV acquisition and transmission and their 
HIV prevalence is higher than heterosexual men 
in their specific country settings.[1] The reasons for 
this are multifactorial but a major risk contributor 
is the high HIV-transmission potential associated with unprotected 
anal intercourse (UAI). Receptive UAI is approximately 16 times 
more likely to result in HIV transmission than unprotected vaginal 
intercourse due to the fact that the anal mucosa is thinner than vaginal 
mucosa and does not self-lubricate before or during intercourse.[2] The 
HIV transmission risk associated with UAI applies equally to women 
engaging in this sexual behaviour. Sexual lubrication is therefore 
required for comfortable, non-traumatic anal sex. Lubricant use has 
also been associated with lower rates of condom failure during anal 
sex among MSM.[3] The use of lubricants for anal sex by MSM ranges 
from 0% in some developing world MSM cohorts to >90% reported 
among MSM communities in the USA.[4,5]
Distribution of condoms and water-based sexual lubricants forms a 
cornerstone of MSM-targeted HIV prevention programmes globally. 
Since HIV prevention interventions have failed among MSM in 
many settings, there is a need to scale up existing evidence-based 
interventions and to explore new prevention technologies that may 
be effective in this high-risk group of men.[4,5] Lubricant distribution 
remains poor in many developing nations and MSM have been 
known to substitute a number of products to ensure comfortable 
anal sex. These include saliva, food products such as egg white, 
yoghurt, jelly and cooking oils and a variety of condom-incompatible 
products such as hand lotions, moisturisers and petroleum jelly. Since 
these products are not normally considered as sexual lubricants, 
they have not been assessed for safety in the rectum. An alternative 
product containing phytosqualane (derived from olives) as the 
active ingredient and called Lubrimaxxx Premium has recently been 
developed by Karl de L’Eau Natural Skincare, Cape Town, as a sexual 
lubricant.
The role of lubricants in preventing HIV gained new prominence 
after studies demonstrated that topical tenofovir-containing products 
(microbicides) could reduce HIV transmission.[6,7] Microbicides could 
be formulated as sexual lubricants and are considered acceptable as 
a potential HIV risk-reduction intervention by MSM if they can be 
used safely for anal sex.[8,9]
Concern has been raised about the potential toxicity of lubricants 
used during anal sex.[10] Epithelial injury is related to the osmolality 
of the lubricant product.[11] The main concern is that hyperosmolar 
water-based lubricants may denude rectal epithelium and increase 
secretion of fluid into the bowel (signalling epithelial injury). 
By compromising the integrity of anal mucosa, lubricant use 
without condoms may increase the risk of HIV transmission.[12] 
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has shown that hyperosmolar products cause epithelial damage 
and that iso-osmolar products are superior.[13] Additionally, there is 
concern that the constituents of some commercially available sexual 
lubricants may increase local HIV replication.[14] These issues are not 
well publicised among key populations who use sexual lubricants for 
comfortable and pleasurable anal sex as well as to reduce their risk 
of HIV infection. Information on the potential toxicity of lubricant 
substitutes used by African MSM is unavailable, making education of 
affected key populations difficult.
Objective
We analysed commercially available water-based sexual lubricant 
products to ascertain their osmolality and potential to cause rectal 
epithelial damage. A phytosqualane-containing formulation, and 
low-fat yoghurt and egg white (common lubricant substitutes), were 
also assessed. 
Methods
Eight of the most frequently purchased water-based sexual lubricants 
were sourced from a leading local adult shop, one of a chain of sex 
shops in South Africa (SA) and from a local non-profit organisation 
distributing lubricant to MSM. KY Jelly and common lubricant 
substitutes (egg white and low-fat yogurt) were also included in the 
analysis, as was the phytosqualane-containing product, Lubrimaxxx 
Premium. Lubricants were diluted 1/10 and 1/50 in deionised 
water for osmolality and glycerol measurement, respectively, using 
positive displacement pipettes. Samples with extremely high glycerol 
concentrations were diluted 1/500 to obtain readings within the 
linear range of the assay employed. Egg albumin and yoghurt were 
diluted 1/2 for measurement of osmolality. Osmolality was measured 
by the Division of Chemical Pathology at the University of Cape 
Town, SA, using a freezing point depression osmometer. Glycerol 
was measured using the enzymatic triglyceride channel on the Roche 
Modular analyser (Roche Diagnostics, Switzerland). 
Results
Osmolality and glycerol measurements are shown in Table  1. 
Osmolality ranged from 270 - 9 440 mosmol/l (Lubrimaxxx Premium, 
containing phytosqualane and JO H2O Water Based Lubricant, 
respectively). Seven (88%) of the commercial lubricants had high 
osmolalities, with two products approaching 10  000  mosmol/l, far 
in excess of serum which has an osmolality of ~280  mosmol/l. 
Exceptions included Leather Personal Lubricant and Lubrimaxxx 
Premium. Egg white and low-fat yoghurt had osmolalities of 276 
and 428 mosm/l, respectively. High osmolality could be attributed to 
glycerol and there was a strong direct correlation between osmolality 
and glycerol content on Wilcoxon matched pair analysis. (p=0.0033).
Discussion
The results of this study show that many of the top-selling brands of 
water-based sexual lubricants available in SA are hyperosmolar. Given 
that hyperosmolar products have been shown in vitro and in vivo to 
cause epithelial injury, they may have the potential to increase HIV 
acquisition and transmission, if they are used during UAI. This is 
particularly concerning since many at-risk MSM utilise these products 
in the belief that they provide protection from HIV infection by 
decreasing friction and resultant trauma to the rectal mucosa. 
Lubricant substitutes vary in their safety. Phytosqualane-
containing lubricants, egg white and plain (unflavoured) low-fat 
yoghurt are relatively isotonic and are therefore unlikely to cause the 
same epithelial injury seen following the use of very hyperosmolar 
lubricants. They could therefore be promoted in countries where 
proprietary lubricants are not freely available, as is the case in most 
African countries. Saliva is also commonly used as a lubricant 
substitute. This is potentially problematic since researchers have 
suggested that this might result in transmission of saliva-borne 
pathogens including herpes and hepatitis viruses.[8,15]
There is currently very little awareness among MSM in SA regarding 
lubricant safety. Manufacturers of sexual lubrication products are not 
required to offer product safety information, which results in the 
inability of users to assess their suitability. It has been demonstrated 
that currently available sexual lubricants do not have anti-HIV effects 
and some may even increase HIV replication.[14] Condom use among 
high-risk men remains inconsistent and therefore lubricant use in the 
absence of condoms is probably commonplace, a practice that may 
increase HIV transmission risk.[16]
Knowledge about HIV prevention technologies is generally low 
among MSM in SA. The work of organisations (such as the Anova 
Health Institute) that provide free MSM-targeted condoms and 
lubricants, and knowledge about utilisation of sexual lubricants, is 
increasing. Lubricant users must understand the risks and benefits 
of these products. Organisations such as the US Centers for Disease 
Control and the World Health Organization advocate the promotion 
of condom and lubricant use among MSM.[17,18] 
Sexual lubricant safety is likely to gain importance as the search for 
a marketable microbicide product continues. Microbicides will need 
Table 1. Osmolality and glycerol measurements
Sexual lubricant product Manufacturer Osmolality (mosmol/l) Glycerol (mmol/l)
JO H2O Water Based United Consortium Inc, USA 9 440 8 500
New H2O Tangerine Dream United Consortium Inc, USA 9 340 8 050
Wet Stuff Vitamin E Gel Works, Australia 7 100 4 025
Lube Original Personal Lubricant Lockerroom Marketing, Canada 5 270 2 435
Assegai Tatt2, SA 4 630 3 450
K-Y Jelly Johnson and Johnson, USA 2 430 1 270
Health4men Lubrimaxxx, SA 1 480 1 265
Leather Personal Lubricant Lockerroom Marketing, Canada 270 30
Plain low-fat yoghurt Dairy Belle, SA 428 36*
Egg white 276 0.1
Lubrimaxxx Premium (phytosqualane) Karl de L’Eau Natural Skincare, SA 270 3
*Triglyceride rather than glycerol.
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to be safe for vaginal and rectal use and their osmolality and potential 
mucosal toxicity are being evaluated. Organisations such as the 
International Rectal Microbicide Advocates (IRMA) are promoting 
this agenda.[19] 
Recommendations
Awareness needs to be raised about the mucosal safety of lubricants 
designed for use during anal sex. This should include community-
based work to educate MSM communities who are currently being 
encouraged to increase lubricant use. Information, education 
and communication (IEC) materials need to be developed and 
distributed that explain the medical concerns that arise when water-
based sexual lubricants are used without condoms. Clearly, MSM-
targeted HIV-risk-reduction messages must stress that lubricants 
should be used together with condoms. For MSM who use 
lubricants alone, advice should be given about the safer use of these 
products such as using silicone-based lubricants and avoiding high 
osmolality water-based products. Some lubricant substitutes such 
as egg white or yoghurt could be promoted, although this will have 
limited impact in countries where food insecurity is common and 
food products are more likely to be consumed than used for sexual 
safety. Phytosqualane-containing, water-based lubricants may offer 
a safe alternative to those that contain glycerine, provided they 
are not too costly. Healthcare workers providing sexual health 
services, inclusive of HIV counsellors, nurses and doctors, need 
to be sensitised to this issue to enable them to provide correct 
risk-reduction counselling to their patients. This information for 
providers and users of lubricants will need to be carefully managed 
to avoid a backlash against use of lubricant and microbicides in 
development.
Lastly, any future microbicide product that is promoted as an HIV-
prevention intervention must be fully analysed to ensure safety by 
assessing any mucosal changes it may induce. 
Study limitations
Only lubricant brands available from one major branch of adult 
shops and selling well in Cape Town during 2012, or available from 
Health4men, were included in this analysis. Popular lubricants used 
by MSM in other geographical settings have not been included. No 
analysis of the ingredients of the various assayed lubricants was 
performed and it is possible that some ingredients may interfere with 
osmolality analyses, although this is not likely. The ingredients and 
preservatives of the various lubricants have not been individually 
assessed for their mucosal toxicity. It is conceivable that a low 
osmolality lubricant may contain toxic additives, making it potentially 
more damaging to anal mucosa than suggested by its osmolality 
alone. 
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